FDA Pursues Consumer Products With Questionable Flu Treatment Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA continues its efforts to protect consumers from the ongoing H1N1 flu outbreak, as well as from opportunistic marketers selling potentially deceptive "cures" for the virus
You may also be interested in...
FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.
FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply
FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney
FDA Learned Consumer Protection Lesson From 2004 Flu Scare
The roster of teams FDA assembled to respond to the 2009-N1H1 flu outbreak includes a consumer protection group to identify potentially dangerous products marketed as cures for the virus